Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Jacobson

Showing results (531-540 of 677) with videos related to

Pageof 68
Sort By:
Translational Vision Science & Technology|January 24, 2023
Color Vision in Blue Cone Monochromacy: Outcome Measures for a Clinical TrialAbraham A Mascio, Alejandro J Roman, Artur V Cideciyan, et al.
Ophthalmology|December 26, 2017
Nonsyndromic Retinitis Pigmentosa in the Ashkenazi Jewish Population: Genetic and Clinical AspectsAdva Kimchi, Samer Khateb, Rong Wen, et al.
Diabetes Care|October 14, 2011
Pharmacokinetics and pharmacodynamics of high-dose human regular U-500 insulin versus human regular U-100 insulin in healthy obese subjectsAmparo de la Peña, Matthew Riddle, Linda A Morrow, et al.
Genes|July 15, 2017
EYS Mutations Causing Autosomal Recessive Retinitis Pigmentosa: Changes of Retinal Structure and Function with Disease ProgressionDavid B McGuigan, Elise Heon, Artur V Cideciyan, et al.
Investigative Ophthalmology & Visual Science|June 30, 2001
Macular pigment and lutein supplementation in retinitis pigmentosa and Usher syndromeT S Aleman, J L Duncan, M L Bieber, et al.
Investigative Ophthalmology & Visual Science|September 28, 2007
Inner retinal abnormalities in X-linked retinitis pigmentosa with RPGR mutationsTomas S Aleman, Artur V Cideciyan, Alexander Sumaroka, et al.
Diabetes, Obesity & Metabolism|June 29, 2016
Basal insulin peglispro versus insulin glargine in insulin-naïve type 2 diabetes: IMAGINE 2 randomized trialM J Davies, D Russell-Jones, J-L Selam, et al.
Investigative Ophthalmology & Visual Science|May 8, 2000
Allelic variation in the VMD2 gene in best disease and age-related macular degenerationA J Lotery, F L Munier, G A Fishman, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 13, 2019
Long-Term Structural Outcomes of Late-Stage RPE65 Gene TherapyKristin L Gardiner, Artur V Cideciyan, Malgorzata Swider, et al.
Human Gene Therapy|September 9, 2008
Treatment of leber congenital amaurosis due to RPE65 mutations by ocular subretinal injection of adeno-associated virus gene vector: short-term results of a phase I trialWilliam W Hauswirth, Tomas S Aleman, Shalesh Kaushal, et al.
Pageof 68

Showing results (531-540 of 677) with videos related to

Sort By:
Pageof 68
Translational Vision Science & Technology|January 24, 2023
Color Vision in Blue Cone Monochromacy: Outcome Measures for a Clinical TrialAbraham A Mascio, Alejandro J Roman, Artur V Cideciyan, et al.
Ophthalmology|December 26, 2017
Nonsyndromic Retinitis Pigmentosa in the Ashkenazi Jewish Population: Genetic and Clinical AspectsAdva Kimchi, Samer Khateb, Rong Wen, et al.
Diabetes Care|October 14, 2011
Pharmacokinetics and pharmacodynamics of high-dose human regular U-500 insulin versus human regular U-100 insulin in healthy obese subjectsAmparo de la Peña, Matthew Riddle, Linda A Morrow, et al.
Genes|July 15, 2017
EYS Mutations Causing Autosomal Recessive Retinitis Pigmentosa: Changes of Retinal Structure and Function with Disease ProgressionDavid B McGuigan, Elise Heon, Artur V Cideciyan, et al.
Investigative Ophthalmology & Visual Science|June 30, 2001
Macular pigment and lutein supplementation in retinitis pigmentosa and Usher syndromeT S Aleman, J L Duncan, M L Bieber, et al.
Investigative Ophthalmology & Visual Science|September 28, 2007
Inner retinal abnormalities in X-linked retinitis pigmentosa with RPGR mutationsTomas S Aleman, Artur V Cideciyan, Alexander Sumaroka, et al.
Diabetes, Obesity & Metabolism|June 29, 2016
Basal insulin peglispro versus insulin glargine in insulin-naïve type 2 diabetes: IMAGINE 2 randomized trialM J Davies, D Russell-Jones, J-L Selam, et al.
Investigative Ophthalmology & Visual Science|May 8, 2000
Allelic variation in the VMD2 gene in best disease and age-related macular degenerationA J Lotery, F L Munier, G A Fishman, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 13, 2019
Long-Term Structural Outcomes of Late-Stage RPE65 Gene TherapyKristin L Gardiner, Artur V Cideciyan, Malgorzata Swider, et al.
Human Gene Therapy|September 9, 2008
Treatment of leber congenital amaurosis due to RPE65 mutations by ocular subretinal injection of adeno-associated virus gene vector: short-term results of a phase I trialWilliam W Hauswirth, Tomas S Aleman, Shalesh Kaushal, et al.
Pageof 68